Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review 2023
14 déc. 2023 05h48 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...